SCHEMBL6940634

SCHEMBL6940634

C=C(N)c1ccc(OCc2ccccc2)c(OC)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.65
RAB9A P51151 2/20 0.65
HPGD P15428 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
SMPD1 P17405 2/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC8 Q9BY41 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
RXRA P19793 1/20 0.57
MRGPRX1 Q96LB2 2/20 0.57
F2 P00734 1/20 0.57
F10 P00742 1/20 0.57
PRSS1 P07477 1/20 0.57
F7 P08709 1/20 0.57
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
ATM Q13315 1/20 0.56
MRGPRX4 Q96LA9 2/20 0.54
ABCB1 P08183 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26258665 0.86 NPC1 (0.65) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL5759617 0.86 PRSS1 (0.70) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL4278415 0.86 NPC1 (0.73) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL16795747 0.84 NPC1 (0.64) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL6455515 0.83 NPC1 (0.70) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL242563 0.82 MRGPRX4 (0.77) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL27881765 0.82 NPC1 (0.77) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL4270566 0.81 SMPD1 (0.73) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL340620 0.81 NPC1 (0.75) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL31025721 0.81 NPC1 (0.75) NPC1RAB9AHPGDSMN1; SMN2SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379523-A1 1,2,3,4-TETRAHYDROISOQUINOLINES DERIVATIVES AS UROTENSIN II RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2004-01-14 EP disclosed
WO-2002076979-A1 1,2,3,4-TETRAHYDROISOQUINOLINES DERIVATIVES AS UROTENSIN II RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2002-10-03 WO disclosed